These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12685820)

  • 1. Ranitidine tablets: an improved dissolution method.
    Eyjolfsson R
    Pharmazie; 2003 Mar; 58(3):220. PubMed ID: 12685820
    [No Abstract]   [Full Text] [Related]  

  • 2. Ranitidine preparations on the Belgian market: a comparative study.
    Saevels J; De Braekeleer K; Corthout J
    J Pharm Belg; 2004; 59(4):100-4. PubMed ID: 15719826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inline filtration of ranitidine hydrochloride solutions.
    Schlatter J; Saulnier JL
    Am J Health Syst Pharm; 1998 Apr; 55(8):840, 843. PubMed ID: 9568242
    [No Abstract]   [Full Text] [Related]  

  • 4. Solubility, dissolution rate and phase transition studies of ranitidine hydrochloride tautomeric forms.
    Mirmehrabi M; Rohani S; Murthy KS; Radatus B
    Int J Pharm; 2004 Sep; 282(1-2):73-85. PubMed ID: 15336383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
    Fahmy RH; Kassem MA
    Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A better dissolution method for ranitidine tablets USP.
    Cappola ML
    Pharm Dev Technol; 2001; 6(1):11-7. PubMed ID: 11247270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative evaluation of the anionic superdisintegrant incorporation mode on the quality of ranitidine tablets].
    Postolache L; Gafiţanu E
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):336-40. PubMed ID: 23077918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation and Evaluation of an in Situ Interpolymer Complex of Carbopol with Polyvinylpyrrolidone as a Matrix for Gastroretentive Tablets of Ranitidine Hydrochloride.
    Yusif RM; Abu Hashim II; Mohamed EA; El Rakhawy MM
    Chem Pharm Bull (Tokyo); 2016; 64(1):42-51. PubMed ID: 26726743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An approach to solvent screening for crystallization of polymorphic pharmaceuticals and fine chemicals.
    Mirmehrabi M; Rohani S
    J Pharm Sci; 2005 Jul; 94(7):1560-76. PubMed ID: 15929066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranitidine HCl: tablet film coating acidity and discoloration.
    Eyjolfsson R
    Drug Dev Ind Pharm; 2000 Jun; 26(6):693-4. PubMed ID: 10826119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization and validation of a dissolution test for famotidine tablets using flow injection analysis.
    Tzanavaras PD; Verdoukas A; Balloma T
    J Pharm Biomed Anal; 2006 May; 41(2):437-41. PubMed ID: 16413732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ranitidine (antacid), food, and formulation on the pharmacokinetics of fostamatinib: results from five phase I clinical studies.
    Flanagan T; Martin P; Gillen M; Mathews D; Lisbon E; Kruusmägi M
    Eur J Clin Pharmacol; 2017 Feb; 73(2):185-195. PubMed ID: 27858108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An environmentally friendly reflectometric method for ranitidine determination in pharmaceuticals and human urine.
    Lima LS; Weinert PL; Lemos SC; Sequinel R; Pezza HR; Pezza L
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jan; 71(5):1999-2004. PubMed ID: 18783980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of ranitidine hydrochloride in water for injection in glass vials and plastic syringes.
    Nahata MC; Morosco RS; Fox J
    Am J Health Syst Pharm; 1996 Jul; 53(13):1588-90. PubMed ID: 8809282
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative bioavailability of two oral formulations of ranitidine.
    Flores-Murrieta FJ; Toledo A; del Carmen Carrasco-Portugal M; Reyes-García G; Rodríguez-Silverio J; Medina-Santillán R; Herrera JE
    Biopharm Drug Dispos; 2006 Jan; 27(1):23-7. PubMed ID: 16278926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrophotometric determination of three anti-ulcer drugs through charge-transfer complexation.
    Al-Ghannam S; Belal F
    J AOAC Int; 2002; 85(5):1003-8. PubMed ID: 12374395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution test for liquid formulations of omeprazole enteric-coated products.
    Jang HJ; Kang BC; Shin WG; Lee S
    Ann Pharmacother; 2003 Jan; 37(1):150-1. PubMed ID: 12503954
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic interaction study between ranitidine and metoclopramide.
    Leucuţa A; Vlase L; Farcău D; Nanulescu M
    Rom J Gastroenterol; 2004 Sep; 13(3):211-4. PubMed ID: 15470533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a method for active drug identification and content determination of ranitidine in pharmaceutical products using near-infrared reflectance spectroscopy: a parametric release approach.
    Rosa SS; Barata PA; Martins JM; Menezes JC
    Talanta; 2008 May; 75(3):725-33. PubMed ID: 18585138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of adjuvants on the speed of dissolution and stability of acetylsalicylic acid in tablets. I. Effects of some disintegrating agents].
    Cid E; Jaminet F
    J Pharm Belg; 1971; 26(1):38-48. PubMed ID: 5559275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.